In a highly publicized case, a former Denver cardiologist was found guilty of 35 out of 38 counts of sexual assault related to women he met on dating apps, continuing as recently as 2023.
Google announced that Loss of Pulse Detection is a new feature on the Pixel Watch 3 smartwatch.
Not counting endurance or professional athletes, researchers found that high levels of physical activity were associated with cardiac remodeling within normal ranges among the general population. (European Heart Journal)
Bristol Myers Squibb has a bone to pick with the newly imposed Maximum Fair Price for apixaban (Eliquis), part of the first round of drugs with negotiated prices under the Inflation Reduction Act.
The Platelet Reactivity ExpreSsion Score (PRESS) has been developed to consider a person’s platelet phenotype when individualizing antithrombotic therapy. (Nature Communications)
Modulation of circulating ketone levels for patients with type 2 diabetes and heart failure with preserved ejection fraction (HFpEF) is supported by positive data from testing a course of oral ketone ester treatment. (Circulation)
In people with HFpEF and excess serum uric acid, add-on serum uric acid-lowering therapy did not help exercise capacity and symptoms over allopurinol alone, a randomized trial found. (JAMA Cardiology)
The lipoprotein(a) lowering of olpasiran was maintained for nearly a year after the last dose in the OCEAN(a)-DOSE trial. (Journal of the American College of Cardiology)
Despite complete endovascular reperfusion, stroke patients can still be left with microvascular perfusion abnormalities that are linked to worse functional status at 90 days. (Stroke)
Hypothermic oxygenated machine perfusion of the donor heart just missed the threshold for significantly improving clinical outcomes for transplant recipients in a randomized trial. (Lancet)
FDA cleared the Acuson Origin, an artificial intelligence-powered cardiovascular ultrasound system, Siemens Healthineers said.
For people with atrial functional mitral regurgitation, mitral valve surgery was linked to better survival and less heart failure hospitalization compared with medical management alone, observational data suggest. (JAMA Network Open)
Researchers designed a new shunt that can accommodate growing children by expanding physically when prompted by a light-emitting catheter, the American Chemical Society (ACS) said.
In other research highlighted by the ACS, scientists are also working on a point-of-care test that can detect heart failure biomarkers from a drop of saliva.
Pending a final FDA approval expected in 2025, treprostinil (Yutrepia) inhalation powder is tentatively approved for adults with pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, Liquidia Corporation said.
-
Nicole Lou is a reporter for MedPage Today, where she covers cardiology news and other developments in medicine. Follow
Please enable JavaScript to view the